We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6186:HKEXChina Feihe Limited Analysis

Data as of 2026-09-05 - not real-time

NT$31.30

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Shin Ruenn development Co., LTD is priced at TWD 31.30 and its moving averages line up in bearish order, the shorter trailing the longer. Over a rolling month the price has lost 25.8%. Relative strength is 24.4 — oversold — and the MACD signal is bullish. Recent trading has carved out support near TWD 31.10 and resistance around TWD 36.10.
Valuation screens as undervalued: a P/E of 6.3 sits below the sector average of 31.3. Revenue is contracting at 85.9% on a 13.4% profit margin. The 15.49% dividend yield looks covered by current payout levels.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 46.4%, a beta of 0.24 and a maximum drawdown of 53.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

Investing7monShin Ruenn Development Co LtdEBITDA Multiple, Enterprise Value / EBITDA, or EV / EBITDA measures the...Investing9monShin Ruenn Development Co LtdPrice-to-Earnings ratio, P/E Multiple, or P/E Ratio is valuation multiple...Find the latest Shin Ruenn development Co.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 24.4 signals oversold conditions
  • Trading below the 200-day average of 44.15

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 24.4 signals oversold conditions
  • P/E of 6.3 versus sector average of 31.3

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 6.3 versus sector average of 31.3
  • Revenue contracting at -85.9%
  • Return on equity of 21.5%

Key Metrics & Analysis

Financial Health

Revenue Growth-85.90%
Profit Margin13.36%
P/E Ratio6.3
ROE21.54%
ROA4.50%
Debt/Equity167.06
P/B Ratio1.3
Op. Cash FlowNT$468.4M
Free Cash FlowNT$1.4B
Industry P/E31.3

Technical Analysis

TrendBearish
RSI24.4
SupportNT$31.10
ResistanceNT$36.10
MA 20NT$32.86
MA 50NT$38.39
MA 200NT$44.15
MACDBullish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Fair ValueNT$56.34
GradeUndervalued
TypeValue
Dividend Yield15.49%

Risk Assessment

Beta0.24
Volatility46.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.